GOLDMAN SACHS GROUP INC - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$42,000
-82.9%
10,755
-48.7%
0.00%–
Q4 2020$246,000
+148.5%
20,984
+10.1%
0.00%–
Q3 2020$99,000–19,061–0.00%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$1,386,4720.33%
Ikarian Capital, LLC 2,765,530$804,7690.13%
JOHNSON & JOHNSON 84,003$24,4450.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$75,3240.00%
Virtu Financial LLC 28,362$80.00%
LINDEN ADVISORS LP 454,916$132,3810.00%
BlackRock Inc. 267,719$77,9060.00%
Bank of New York Mellon Corp 10,259$2,9850.00%
HRT FINANCIAL LP 49,165$140.00%
MGO ONE SEVEN LLC 11,780$3,4280.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders